YM155, a Novel Survivin Suppressant, Improves the Antitumor Effect of Rituximab and Rituximab-Containing Regimens in Diffuse Large B Cell Lymphoma (DLBCL) Xenograft Mouse Models

被引：0
|
作者：
Nakata, Mari [1 ]
Nakahara, Takahito [1 ]
Kita, Aya [1 ]
Mitsuoka, Keisuke [1 ]
Yamanaka, Kentaro [1 ]
Kaneko, Naoki [1 ]
Miyoshi, Sosuke [1 ]
Mori, Masamichi [1 ]
Koutoku, Hiroshi [1 ]
Sasamata, Masao [1 ]
机构：
[1] Astellas Pharma Inc, Drug Discovery Res, Tsukuba, Ibaraki, Japan
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1064 / 1064
页数：1
相关论文
共 50 条
  • [21] Therapeutic impact of Rituximab® containing stem cell mobilization regimens in diffuse large B-cell lymphoma
    Szomor, A.
    David, M.
    Vidra, T.
    Losonczy, H.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S152 - S152
  • [22] Rituximab improves outcome in patients with diffuse large B-cell lymphoma (DLBCL) -: Single centre retrospective study
    Belada, D
    Zak, P
    Sykorová, A
    Zavrelová, A
    Smolej, L
    Maly, J
    ANNALS OF ONCOLOGY, 2005, 16 : 178 - 178
  • [23] No Benefit from Rituximab Containing Regimens in Patients with Primary Extranodal Diffuse Large B-Cell Lymphoma
    Gutierrez-Garcia, Gonzalo
    Colomo, Luis
    Villamor, Neus
    Arenillas, Leonor
    Martinez, Antonio
    Camsos, Mireia
    Diaz-Beya, Marina
    de Larrea, Carlos Fernandez
    Calvo, Xavier
    Gine, Eva
    Bosch, Francesc
    Campo, Elias
    Montserrat, Emili
    Lopez-Guillermo, Armando
    BLOOD, 2008, 112 (11) : 1237 - 1237
  • [24] Late-onset neutropenia following primary treatment of diffuse large B-cell lymphoma with rituximab-containing therapy
    Rozman, Samo
    Sonc, Monika
    Novakovic, Barbara Jezersek
    LEUKEMIA & LYMPHOMA, 2012, 53 (10) : 1945 - 1948
  • [25] Addition of rituximab (R) to CHOP improves survival in the non-GCB subtype of diffuse large B cell lymphoma (DLBCL).
    Farinha, Pedro
    Sehn, Laurie
    Skinnider, Brian
    Connors, Joseph M.
    Gascoyne, Randy D.
    BLOOD, 2006, 108 (11) : 245A - 245A
  • [26] USE OF STATINS AND PROGNOSIS IN PATIENTS WITH CD20-POSITIVE 'DE NOVO' DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) TREATED WITH RITUXIMAB CONTAINING REGIMENS
    Madsen, J.
    Nielsen, R.
    Engebjerg, M.
    Sorensen, H.
    Bukh, A.
    D'Amore, F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 282 - 282
  • [27] Comparison of B-Cell Lineage and Prognostic Markers before and after Therapy with Rituximab-Containing Regimen in Diffuse Large B-Cell Lymphoma (DLBCL) and Chronic Lymphocytic Leukemia (CLL)
    Mahon, B. M.
    Chen, Y.
    LABORATORY INVESTIGATION, 2010, 90 : 309A - 309A
  • [28] Comparison of B-Cell Lineage and Prognostic Markers before and after Therapy with Rituximab-Containing Regimen in Diffuse Large B-Cell Lymphoma (DLBCL) and Chronic Lymphocytic Leukemia (CLL)
    Mahon, B. M.
    Chen, Y.
    MODERN PATHOLOGY, 2010, 23 : 309A - 309A
  • [29] RITUXIMAB IMPROVES QUALITIY OF RESPONSE AND SURVIVAL IN ELDERLY PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): A POPULATION-BASED STUDY
    Garcia-Sanchis, L.
    Teruel, A.
    Amat, P.
    Goterris, R.
    Ferrandez, A.
    Solano, C.
    Terol, M. J.
    ANNALS OF ONCOLOGY, 2011, 22 : 227 - 228
  • [30] Hepatic toxicity and prognosis in hepatitis C virus-infected patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy regimens: a Japanese multicenter analysis
    Ennishi, Daisuke
    Maeda, Yoshinobu
    Niitsu, Nozomi
    Kojima, Minoru
    Izutsu, Koji
    Takizawa, Jun
    Kusumoto, Shigeru
    Okamoto, Masataka
    Yokoyama, Masahiro
    Takamatsu, Yasushi
    Sunami, Kazutaka
    Miyata, Akira
    Murayama, Kayoko
    Sakai, Akira
    Matsumoto, Morio
    Shinagawa, Katsuji
    Takaki, Akinobu
    Matsuo, Keitaro
    Kinoshita, Tomohiro
    Tanimoto, Mitsune
    BLOOD, 2010, 116 (24) : 5119 - 5125
12345